115 related articles for article (PubMed ID: 951726)
1. Statewide support of thrombocytopenic patients with ABO matched single donor platelets.
Reiss RF; Katz AJ
Transfusion; 1976; 16(4):312-20. PubMed ID: 951726
[TBL] [Abstract][Full Text] [Related]
2. HLAMatchmaker is effective for selecting appropriate platelet units for alloimmunised thrombocytopaenic patients who are refractory to random donor platelets.
O'Rafferty C; Rooney G; Hagan R; Woolfson M; O'Donghaile D; Fitzgerald J
Transfus Med; 2017 Oct; 27 Suppl 5():369-374. PubMed ID: 28393455
[TBL] [Abstract][Full Text] [Related]
3. The transfusion of HLA-matched platelets to thrombocytopenic patients resistant to random donor platelets.
Levy L; Woodfield DG
N Z Med J; 1984 Oct; 97(766):719-21. PubMed ID: 6595558
[TBL] [Abstract][Full Text] [Related]
4. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis.
Daly PA; Schiffer CA; Aisner J; Wiernik PH
Transfusion; 1979; 19(6):778-81. PubMed ID: 524435
[TBL] [Abstract][Full Text] [Related]
5. Plateletpheresis using the haemonetics model 30 cell separator.
Nusbacher J; Scher ML; MacPherson JL
Vox Sang; 1977 Jul; 33(1):9-15. PubMed ID: 883246
[TBL] [Abstract][Full Text] [Related]
6. Cross-match-compatible platelets improve corrected count increments in patients who are refractory to randomly selected platelets.
Elhence P; Chaudhary RK; Nityanand S
Blood Transfus; 2014 Apr; 12(2):180-6. PubMed ID: 24333069
[TBL] [Abstract][Full Text] [Related]
7. ABO compatibility and platelet transfusions of alloimmunized thrombocytopenic patients.
Duguesnoy RJ; Anderson AJ; Tomasulo PA; Aster RH
Blood; 1979 Sep; 54(3):595-9. PubMed ID: 465731
[TBL] [Abstract][Full Text] [Related]
8. Successful transfusion of platelets "mismatched" for HLA antigens to alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Rodey GE; Rimm AA; Aster RH
Am J Hematol; 1977; 2(3):219-26. PubMed ID: 596366
[TBL] [Abstract][Full Text] [Related]
9. ABO compatibility can influence the results of platelet transfusion. Results of a randomized trial.
Lee EJ; Schiffer CA
Transfusion; 1989 Jun; 29(5):384-9. PubMed ID: 2660333
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
[TBL] [Abstract][Full Text] [Related]
11. [Experience of HLA-matched platelet transfusion in patients who are refractory to random donor platelets].
Sekiguchi S; Mitani T; Ohnuma M; Katoh T; Ikeda H; Nakase T; Morioka M; Sakurada K; Miyazaki T
Hokkaido Igaku Zasshi; 1988 Jul; 63(4):552-61. PubMed ID: 3220437
[TBL] [Abstract][Full Text] [Related]
12. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA.
McVey M; Cserti-Gazdewich CM
Transfus Med; 2010 Oct; 20(5):346-53. PubMed ID: 20492602
[TBL] [Abstract][Full Text] [Related]
13. Frozen autologous platelet transfusion for patients with leukemia.
Schiffer CA; Aisner J; Wiernik PH
N Engl J Med; 1978 Jul; 299(1):7-12. PubMed ID: 661855
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
[TBL] [Abstract][Full Text] [Related]
15. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion.
Rioux-Massé B; Cohn C; Lindgren B; Pulkrabek S; McCullough J
Transfusion; 2014 Dec; 54(12):3080-7. PubMed ID: 24916382
[TBL] [Abstract][Full Text] [Related]
16. [Substitution ofpolysensitized patients with platelets from HL-A typed single donors].
Gmür J; Baumberger U; von Felten A
Schweiz Med Wochenschr; 1976 Oct; 106(40):1358-9. PubMed ID: 1006253
[TBL] [Abstract][Full Text] [Related]
17. Factors that influence platelet recovery after transfusion: resolving donor quality from ABO compatibility.
Jiménez TM; Patel SB; Pineda AA; Tefferi A; Owen WG
Transfusion; 2003 Mar; 43(3):328-34. PubMed ID: 12675717
[TBL] [Abstract][Full Text] [Related]
18. Donor selection in platelet transfusion therapy of alloimmunized thrombocytopenic patients.
Duqesnoy RJ
Prog Clin Biol Res; 1978; 28():229-43. PubMed ID: 88057
[No Abstract] [Full Text] [Related]
19. Matching of histocompatibility (HL-A) antigens for platelet transfusion.
Mittal KK; Ruder EA; Green D
Blood; 1976 Jan; 47(1):31-41. PubMed ID: 1244913
[TBL] [Abstract][Full Text] [Related]
20. Influence of HLA-A2 on the effectiveness of platelet transfusions in alloimmunized thrombocytopenic patients.
Duquesnoy RJ; Filip DJ; Aster RH
Blood; 1977 Sep; 50(3):407-12. PubMed ID: 884318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
